Proficio Capital Partners LLC bought a new position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 56,131 shares of the health services provider's stock, valued at approximately $510,000.
A number of other large investors have also bought and sold shares of the business. Versant Capital Management Inc boosted its stake in Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after purchasing an additional 2,441 shares in the last quarter. Whipplewood Advisors LLC bought a new position in shares of Teladoc Health in the fourth quarter worth about $29,000. KBC Group NV lifted its position in shares of Teladoc Health by 72.3% during the fourth quarter. KBC Group NV now owns 8,849 shares of the health services provider's stock worth $80,000 after purchasing an additional 3,714 shares in the last quarter. Westside Investment Management Inc. grew its stake in shares of Teladoc Health by 43.8% during the fourth quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider's stock valued at $84,000 after purchasing an additional 2,800 shares during the last quarter. Finally, GSA Capital Partners LLP bought a new position in Teladoc Health in the 3rd quarter valued at $92,000. 76.82% of the stock is currently owned by institutional investors.
Teladoc Health Stock Down 1.1 %
NYSE:TDOC traded down $0.10 on Thursday, hitting $8.55. The stock had a trading volume of 4,197,600 shares, compared to its average volume of 7,731,415. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 52 week low of $6.76 and a 52 week high of $15.43. The business's fifty day moving average is $10.38 and its 200 day moving average is $9.77. The company has a market cap of $1.48 billion, a PE ratio of -1.48 and a beta of 1.27.
Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). The firm had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, equities research analysts expect that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on TDOC shares. Oppenheimer reduced their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research note on Friday, January 24th. The Goldman Sachs Group dropped their price target on Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a research note on Monday, March 3rd. Bank of America lifted their price objective on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a "neutral" rating in a research report on Wednesday, February 12th. Piper Sandler dropped their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a report on Thursday, February 27th. Eleven equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $11.26.
Get Our Latest Report on Teladoc Health
Insider Transactions at Teladoc Health
In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the company's stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the sale, the insider now directly owns 64,308 shares of the company's stock, valued at approximately $541,473.36. This represents a 14.62 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.95% of the stock is currently owned by insiders.
About Teladoc Health
(
Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Recommended Stories
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
